Q4 2017
Released Mar 12, 2018, before the open
10-K filed Mar 12, 2018, 71 days after period end · 0001144204-18-013981
Q4 2017 · 10-K
Revenue$0.00$0.00 derivedno prior Q4 2016 on fileno prior Q3 2017 on file
Net Income-$5.33M-$5.33M N/M vs Q4 2016N/M vs Q3 2017
EPS Diluted-$0.25-$0.25 N/M vs Q4 2016N/M vs Q3 2017
Operating Income-$5,402,384N/M
Operating Cash Flowderived-$4,296,952N/M
Free Cash Flowderived-$4,296,952N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$5.33M | -$2.97M | -$4.63M | -$4.04M |
| EPS Diluted | -$0.25 | -$0.16 | -$0.25 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR